A somatostatin receptor 1 selective ligand inhibits Ca2+ currents in rat insulinoma 1046-38 cells

FEBS Letters
D RoostermanW Meyerhof

Abstract

Rat insulinoma 1046-38 cells represent a model system to study beta-cell function. The mRNAs for sst1 and sst2, two of the five somatostatin receptors, were detected by reverse transcription polymerase chain reaction amplification in these cells. Displacement binding analysis suggested that sstl represents the major somatostatin receptor subtype. The sstl selective compound CH-275 did not inhibit adenylyl cyclases while compounds that activated sst2 did. In contrast, CH-275 caused a marked inhibition of voltage-operated Ca2+ channels while the sst2 specific analog octreotide elicited a less pronounced effect suggesting that in rat insulinoma 1046-38 cells sst1 preferably mediates the inhibition of Ca2+ channels.

References

Aug 31, 1984·Neuroscience Letters·J C Reubi
Aug 1, 1981·Pflügers Archiv : European journal of physiology·O P HamillF J Sigworth
Mar 15, 1995·European Journal of Pharmacology·D HoyerJ C Reubi
Nov 1, 1994·Naunyn-Schmiedeberg's Archives of Pharmacology·D HoyerC Bruns
Aug 23, 1996·The Journal of Biological Chemistry·G LiapakisT Reisine
Jul 1, 1997·Gastroenterology·G GlassmeierH Scherübl

❮ Previous
Next ❯

Citations

Apr 14, 2004·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·C BousquetC Susini
Nov 23, 2000·Journal of Physiology, Paris·G FerjouxC Susini
Feb 3, 1999·Annals of the New York Academy of Sciences·H Baumeister, W Meyerhof
May 16, 2001·General and Comparative Endocrinology·S G DedosM Takamiya
Mar 12, 2013·International Journal of Peptides·Federica BarbieriTullio Florio
Aug 15, 2009·Expert Opinion on Investigational Drugs·Pavlos MsaouelMichael Koutsilieris
Oct 12, 2004·Clinical Endocrinology·Robyn L AdamsStephen L Atkin
Aug 28, 2003·Alimentary Pharmacology & Therapeutics·H Reynaert, A Geerts
Apr 2, 2016·Drug Development and Industrial Pharmacy·Ahmed A H AbdellatifHesham M Tawfeek
Sep 27, 2005·Best Practice & Research. Clinical Gastroenterology·Julie Guillermet-GuibertChristiane Susini
Apr 3, 2001·The Journal of Physiology·P A SmithP P Humphrey
Aug 28, 2007·Pharmacology & Therapeutics·Davide Cervia, Paola Bagnoli
May 22, 2004·Annals of the New York Academy of Sciences·Hicham LahlouChristiane Susini
Aug 17, 2019·Drug Development and Industrial Pharmacy·Ahmed A H Abdellatif
Oct 1, 1998·Biochemical and Biophysical Research Communications·G GlassmeierH Scherübl
Aug 6, 1999·Frontiers in Neuroendocrinology·Y C Patel
May 18, 1999·Biochemical and Biophysical Research Communications·L ChenA H Tashjian
Sep 26, 2003·Biochimica Et Biophysica Acta·Lars Neisig MøllerJens Juul Holst

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.